Clinical Trial Update: Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gabapentin and memantine for pendular nystagmus in patients with multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Gabapentin (Gabapentin)
• Memantine (memantine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Pendular Nystagmus Patients With Multiple Sclerosis | Phase 2 | Status: COMPLETED